About this document
FDA Urged to Combat Counterfeit GLP-1 Drugs by jocelyn.allison is a document available to read on EtoBox.
State attorneys general are urging the FDA to take action against illegal activities surrounding GLP-1 drugs, including counterfeit medications and unregulated online sales. They highlight the dangers posed by these counterfeit drugs, which can contain harmful substances, and the risks associated with self-formulating medications from active ingredients sold without prescriptions. The letter calls for increased enforcement and collaboration with federal partners to protect consumers from unsafe and unregula
- Author
- jocelyn.allison
- Language
- EN